EMD Emyria Limited
—Mkt Cap: —P/E: —1d ago
Emyria Limited engages in delivering and developing of treatments for mental health and select neurological conditions in Australia. The company operates through Clinical Services and corporate segments. It provides ther…
Industry Peers
Health Information Services$50.68BUSDP/E 52.1
$12.83BUSD
$12.34BUSDP/E 55.2
$8.47BUSDP/E 34.6
$7.65BUSDP/E 33.5
$5.61BUSDP/E 37.1
$5.41BUSDP/E 39.2
$4.43BUSD
$2.89BUSDP/E 107.7
$1.91BUSD
$1.64BUSDP/E 43.8
$1.47BUSD
$1.20BUSDP/E 70.1
$1.14BUSDP/E 77.8
$1.08BUSD
$1.03BUSDP/E 46.9
$685.26MUSDP/E 64.9
$620.58MUSD
$594.53MUSD
$580.72MUSDP/E 31.4
Key Statistics
Company
Market Cap—
Enterprise Value17.80M USD
Revenue (TTM)2.80M USD
Gross Profit635.34K USD
Net Income (TTM)-4.23M USD
Revenue/Share0.0050 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryHealth Information Services
ISINAU0000073645
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-5.24
EV/Revenue6.35
P/S7.96
P/B3.64
EPS (TTM)-0.01
EPS (Forward)—
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin22.68%
Oper. Margin-122.83%
EBITDA Margin-121.22%
Profit Margin-150.84%
ROE-86.41%
ROA-34.65%
Growth
Revenue Growth239.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.15M USD
CapEx (TTM)855.71K USD
FCF Margin-58.79%
FCF Yield—
Net Debt-4.49M USD
Net Debt/EBITDA1.32
Balance Sheet
Debt/Equity0.71
Current Ratio4.36
Quick Ratio4.13
Book Value/Sh0.01 AUD
Cash/Share0.0090 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.806.69M
Float591.22M
Insiders25.82%
Institutions0.00%
Technical
SMA 500.0461 AUD
SMA 2000.0473 AUD
Beta0.02
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)1.15M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—